BioArctic AB (publ)
BRCTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.57 | -0.05 | 26.27 | -2.50 |
| FCF Yield | -1.92% | 1.26% | -0.17% | -0.65% |
| EV / EBITDA | -82.50 | 79.28 | 6,400.04 | -169.03 |
| Quality | ||||
| ROIC | -22.49% | 19.69% | -2.19% | -14.81% |
| Gross Margin | 89.51% | 85.45% | 67.44% | -137.91% |
| Cash Conversion Ratio | 1.38 | 1.23 | 1.81 | 1.01 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.07% | 198.56% | 54.13% | -56.53% |
| Free Cash Flow Growth | -213.47% | 780.99% | 69.36% | -38.19% |
| Safety | ||||
| Net Debt / EBITDA | 2.17 | -2.05 | -197.60 | 6.58 |
| Interest Coverage | -123.59 | 666.60 | -31.20 | -166.73 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -581.48 | -121.50 | -105.54 | -27.30 |